Literature DB >> 23609127

Transvitreal fibrinoid pseudoendophthalmitis after diabetic vitrectomy.

Caesar Luo1, Alan Ruby, Melissa Neuwelt, George A Williams.   

Abstract

OBJECTIVE: To describe the presentation and clinical course of noninfectious transvitreal fibrinoid response after vitrectomy for diabetic retinopathy.
METHODS: Data collected from charts included age, gender, surgical indication, preoperative and serial visual acuities, vitrectomy procedures, and postoperative clinical characteristics of involved eye.
RESULTS: Patients had a mean age of 65.6 years (51-82 years) with 5 women and 2 men. Patients had a range of diabetes duration from 4 to 27 years and a mean HgbA1C of 9.1 (5.8-14.1). Surgical indications included nonclearing vitreous hemorrhage (five), tractional retinal detachment (three), and clinically significant macular edema (one). All patients manifested transvitreal bands on postoperative Day 1 without anterior chamber reaction. Mean time to resolution of transvitreal bands was 8.75 days (4-15 days) on standard postoperative topical medications alone.
CONCLUSION: Transvitreal fibrinoid response after diabetic vitrectomy is a remarkable phenomenon that can occur in a wide variety of patients with diabetic retinopathy. It is important to differentiate this from infectious endophthalmitis, as this series of cases resolved spontaneously on topical medications alone.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23609127     DOI: 10.1097/IAE.0b013e31828abe67

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  2 in total

1.  Transvitreal and subretinal fibrinoid reaction following diabetic vitrectomy.

Authors:  Andrew J Nelson; Neesurg S Mehta; Jorge R Ochoa; Caesar Luo; Kareem Moussa
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-24

Review 2.  Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: a case report and review of the literature.

Authors:  Anton M Kolomeyer; Christopher K Hwang; Benjamin J Kim
Journal:  J Med Case Rep       Date:  2018-11-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.